Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation

Immunology

Volumn 113, Issue 1, 2004, Pages 57-64

  Pan, Tai Long ^a   Wang, Pei Wen ^a   Huang, Chao Chen ^b   Goto, Shigeru ^b   Chen, Chao Long ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Allograft tolerance; Haptoglobin; Mixed lymphocyte reaction; Orthotopic liver transplantation; Proteomics

Indexed keywords

HAPTOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; RAT; REGULATORY MECHANISM; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PROTEINS; CELL DIVISION; HAPTOGLOBINS; IMMUNE TOLERANCE; INTERLEUKIN-2; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MOLECULAR SEQUENCE DATA; POSTOPERATIVE PERIOD; PROTEOMICS; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 4444321910     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01924.x     Document Type: Article

References (31)

1. Billingham RE, Brent L, Medawar PB. Quantitative studies on tissue in transplant immunity. Proc R Soc 1954; 143:58-80.
2. Zimmermann FA, Davies HS, Knoll PP, Gokel JM, Schmidt T. Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation 1984; 37:406-10.
3. Kamada N, Davies HS, Brons G. Reversal of transplantation immunity by liver grafting. Nature 1981; 292:840-2.
4. Kamada N, Sumimoto R, Baguerizo A, Yoshimatsu A, Teramoto K, Yamaguchi A. Mechanisms of transplantation tolerance by liver grafting in rats: involvment of serum factors in clonal deletion. Immunology 1988; 64:315-7.
5. Goto S, Lord R, Kobayashi E, Vari F, Edwards-Smith C, Kammada N. Novel immunosuppressive proteins purified from the serum of liver retransplantation rats. Transplantation 1996; 61:1147-51.
6. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17:577.
7. Bishop GA, McCaughan GW, Sun J, Aheil AG. Microchimerism and transplant tolerance. Immunol Today 1997; 18:455-6.
8. Riordan SM, Williams R. Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn? J Hepatol 1999; 31:1106-19.
9. Goddard S, Adams DH. New approaches to immunosuppression in liver transplantation. J Gastrol Hepatol 2002; 17:116-26.
10. Yeatman TJ. The future of cancer management. Translating the genome, transcriptome, and proteome. Ann Surg Oncol 2003; 10:7-14.
11. Kennedy S. Proteomic profiling from human samples: the body fluid alternative. Toxicol Lett 2001; 120:379-84.
12. Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998; 19:1853-61.
13. Patterson SD, Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis 1995; 16:1791-814.
14. Kamada N, Kobayashi E, Goto S. Liver transplantation in the rat. In: Green, MK, Mandel, TE, eds. Experimental Transplantation Models in Small Animals. Chur, Switzerland: Harwood Academic Publishers, 1995:341-52.
15. Altshul SF, Madden TL, Schaffer AA, Zang J, Zang Z, Miller W, Lipman D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997; 25:3389-402.
16. Gevaert K, Demol. H, Martens L et al. Protein identification based on matrix assisted laser desorption/ionization-post source decay-mass spectrometry. Electrophoresis 2001; 22:1645-51.
17. Toogood GJ, Rankin AM, Tam PK, Morris PJ, Dallman MJ. The immune response following small bowel transplantation. I. An unusual pattern of cytokine expression. Transplantation 1996; 62:851-5.
18. Pan TL, Goto S, Lin YC et al. The fas and fas ligand pathways in liver allograft tolerance. Clin Exp Immunol 1999; 118:180-7.
19. Marinkovic S, Baumann H. Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene. Mol Cell Biol 1990; 10:1573-83.
20. VanBuskirk AM, Adams PW, Orosz CG. Nonradioactive alternative to clinical mixed lymphocyte reaction. Hum Immunol 1995; 43:38-44.
21. Lord R, Kamada N, Kobayashi E, Goto S, Sunagawa M. Isolation of a 40 kDa immunohibitory protein induced by rat liver transplantation. Transplant Immunol 1995; 3:174-9.
22. Kamrin BB. Role of alpha globulins in immunosuppression: reactive site occlusion hypothesis. Transpl Proc 1969; 1:506-10.
23. Apffel CA, Peters JH. Tumors and serum glycoproteins. The 'symbodies.'. Prog Exp Tumor Res 1969; 12:1-54.
24. Oh SK, Very DL, Walker JE. Interference with immune response at the level of generating effector cells by tumor-associated haptoglobin. J Natl Cancer Inst 1990; 82:934-40.
25. O'Bryan MK, Grima J, Mruk D, Cheng CY. Haptoglobin is a sertoli cell product in the rat seminiferous epithelium: its purification and regulation. J Androl 1997; 18:637-45.
26. Arredouani M, Matthijs P, Hoeyveld EV, Kasran A, Baumann H, Ceuppens JL, Stevens E. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003; 108:144-51.
27. Lord R, Goto S, Pan T, Chiang K, Chen C, Sunagawa M. Peak protein expression of IL-2 and IFN-gamma correlate with the peak rejection episode in a spontaneously tolerant model of rat liver transplantation. Cytokine 2001; 13:155-61.
28. Frings W, Dreier J, Sorg C. Only the soluble form of the scavenger CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has not effect. FEBS 2002; 526:93-6.
29. Zuo XJ, Nicolaidou E, Okada Y, Toyoda M, Jordan SC. Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) In vitro. Transpl Immunol 2001; 9:1-6.
30. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Mat Med 2003; 9:206-12.
31. Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 1990; 50:678-82.